Le Lézard
Classified in: Health
Subjects: SVY, WOM, FVT

Mind, Mood and our Microbiome: Emerging Connections


NEW YORK, Oct. 19, 2017 /PRNewswire-USNewswire/ -- It was first thought that the brain was separate from other organs and functions in the body, but more and more we are seeing research revealing a connection between our brains and the rest of our body. One such connection is between our brain and our gut, directly impacting our mind, mood and microbiome. But what do these connections mean and how do they each influence each other? Can your gut health affect depression and anxiety? And vice versa, how do your nerves affect your gut? What is the link between the brain and the immune system?

Weill Cornell Medicine (PRNewsFoto/Weill Cornell Medicine)

These questions and many more will be addressed during the 35th annual Women's Health Symposium Luncheon, moderated by Dr. Orli Etingin, director of the Iris Cantor Women's Health Center.

All proceeds from the event, chaired by Joan Weill and Dr. Orli Etingin, will benefit the center.

WHO: David Artis, PhD, Director, Jill Roberts Institute for Research in Inflammatory Bowel Disease, Michael Kors Professor in Immunology, Weill Cornell Medicine

Conor Liston, MD, PhD, Assistant Professor of Neuroscience and Psychiatry,
Weill Cornell Medicine; Assistant Attending Psychiatrist at NewYork-Presbyterian/Weill Cornell Medical Center

Drs. Artis and Liston will give a dynamic presentation on fascinating new insights into the communication between the brain and gut. These Weill Cornell Medicine and NewYork-Presbyterian experts in brain signaling and the gut microbiome will discuss how clinical conditions, such as depression, anxiety, learning difficulty and immune deficiency, may all arise from altered brain?gut signaling pathways. They will discuss these discoveries, as well as potential new forms of prevention and treatment of common conditions like diabetes, obesity and arthritis.

Dr. Etingin will join Drs. Artis and Liston for a Q-and-A following the presentation. The panel will answer questions from the audience.   

WHEN: Tuesday, Oct. 24

WHERE: Citigroup Executive Conference Center
153 East 53rd Street, New York, New York 10022
(Between Lexington and Third Avenue)

http://weill.cornell.edu/womens_health_symposium/

 

 

SOURCE Weill Cornell Medicine


These press releases may also interest you

26 avr 2024
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

26 avr 2024
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

26 avr 2024
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

26 avr 2024
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

26 avr 2024
David J. Dykeman, co-chair of the Life Sciences & Medical...

26 avr 2024
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...



News published on and distributed by: